POSTER SESSION III & CONTINENTAL BREAKFAST

PS3-1

COST-EFFECTIVENESS ANALYSIS OF PLEURX® CATHETER VS. TALC PLEURODESIS FOR THE TREATMENT OF MALIGNANT PLEURAL EFFUSIONS: A MARKOV MODEL

Iñigo Bermejo, MSc¹, Maria José Roca, PhD² and Francisco J. Díez, PhD¹, (1)UNED, Madrid, Spain, (2)Hospital Universitario Virgen de la Arrixaca de Murcia, El Palmar, Spain

PS3-2

IDENTIFYING CULTURAL INFLUENCES ON PATIENTS' DESIRED LEVELS OF PARTICIPATION IN MEDICAL DECISION MAKING: A MULTI-CULTURAL INVESTIGATION

Dana Alden, MBA, MA, PhD¹, Khatijah Lim Abdullah, BSc, MSc, DClinP², John Friend, PhD¹, Sorapop Kiatpongsan, MD, PhD³, Ping Yein Lee, MBBS, MFamMed⁴, Yew Kong Lee, BA, PhD⁵, Supanida Limpongsanurak⁶, Chirk Jenn Ng, MBBS, MMed(Fam Med), PhD⁷, Miho Tanaka, PhD, MPH⁸, Lyndal Trevena, MBBS, MPhilPH, PhD⁹, Katrina Tsang, MBChB¹⁰ and Huso Yi, PhD¹¹, (1)Shidler College of Business, University of Hawaii, Honolulu, HI, (2)Department of Nursing Science, University of Putra Malaysia, Kuala Lumpur, Malaysia, (3)Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, (4)Department of Family Medicine, University of Putra Malaysia, Serdang, Malaysia, (5)University of Malaya, Kuala Lumpur, Malaysia, (6)Medical Student, Chulalongkorn University, Bangkok, Thailand, (7)Department of Primary Care Medicine, University of Malaya, Kuala Lumpur, Malaysia, (8)Health Services Research & Development Service, Washington DC, DC, (9)School of Public Health, The University of Sydney, Sydney, Australia, (10)The Chinese University of Hong Kong, Hong Kong, China, (11)CUHK Centre for Bioethics, The Chinese University of Hong Kong, Hong Kong, China

PS3-3

A DISCRETE EVENT MODEL FOR ASSESSING THE COST-EFFECTIVENESS OF PRECISION MEDICINE INITIATIVES

John Graves, PhD¹, Jonathan Schildcrout, MS, PhD², Yaping Shi, MS¹, Xiaoming Wang, MS², Ramya Marathi, MS², Julie Field, PhD², James Stahl, MD, CM, MPH³ and Josh Peterson, MD, MPH¹, (1)Vanderbilt University School of Medicine, Nashville, TN, (2)Vanderbilt University Medical Center, Nashville, TN, (3)Massachusetts General Hospital, Boston, MA

PS3-4

COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL NEWBORN SCREENING FOR SEVERE COMBINED IMMUNE DEFICIENCY IN WASHINGTON STATE

Scott Grosse¹, Yao Ding², John Thompson³, Lisa Kobrynski⁴, Jelili Ojodu² and Guisou Zarbalian², (1)Centers for Disease Control and Prevention, Atlanta, GA, (2)Association of Public Health Laboratories, Silver Spring, MD, (3)Washington State Department of Health, Shoreline, WA, (4)Emory University School of Medicine, Atlanta, GA

PS3-5

COMPARATIVE EFFECTIVENESS AND COST EFFECTIVENESS OF GENERIC ALENDRONATE, RISEDRONATE, DENOSUMAB AND ZOLEDRONIC ACID FOR SECONDARY PREVENTION OF FRAGILITY FRACTURES- PRELIMINARY RESULTS

Gunhild Hagen, M.Phil., Institute of Public Health, Norwegian University of Science and Technology, Trondheim, Norway, Ivar Sønbø Kristiansen, MD, PhD, MPH, University of Oslo, Oslo, Norway and Torbjørn Wisløff, MSc, PhD, Oslo University Hospital & University of Oslo, Oslo, Norway

PS3-6

COST-EFFECTIVENESS OF INITIAL MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY VERSUS A RISK STRATIFICATION ALGORITHM FOR MANAGEMENT OF SUSPECTED CHOLEDOCHOLITHIASIS

Stella Kang, MD, David Hoffman, MD and R. Scott Braithwaite, MD, MSc, FACP, New York University School of Medicine, New York, NY

PS3-7

PALIVIZUMAB FOR USE IN INFANTS WITH CYSTIC FIBROSIS: EFFECTIVENESS AND COST-EFFECTIVENESS

Ashleigh McGirr, MPH¹, Kevin Schwartz, MD², Upton Allen, MD MSc², Melinda Solomon, MD² and Beate Sander³, (1)Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, (2)The Hospital for Sick Children, Toronto, Toronto, ON, Canada, (3)Public Health Ontario, Toronto, ON, Canada

PS3-8

COST-EFFECTIVENESS OF PROPOFOL VS DEXMEDETOMIDINE FOR MILD TO MODERATE SEDATION DURING MECHANICAL VENTILATION

Bianka Nguyen, BS¹, Chiedozie Udeh, MD², Phuc Le, PhD³, Joe Zein, MD⁴, Simon Lam, PharmD, RPh⁵ and Belinda Udeh, PhD, MPH¹, (1)Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, (2)Critical Care Center and Department of Cardiothoracic Anesthesiology, Cleveland Clinic, Cleveland, OH, (3)Center for Value-based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, OH, (4)Departments of Pulmonary Medicine and Critical Care Medicine, Cleveland Clinic, Cleveland, OH, (5)Department of Pharmacy, Cleveland Clinic, Cleveland, OH

PS3-9

PHARMACOECONOMIC MODELING OF BIOSIMILARS IN THE US: A CONCEPTUAL FRAMEWORK

Tanya G.K. Bentley, PhD, Ayanna Anene, BS and Michael S. Broder, MD, MSHS, Partnership for Health Analytic Research, LLC, Beverly Hills, CA

PS3-10

MENISCAL ALLOGRAFT TRANSPLANTATION IS A COST-EFFECTIVE ALTERNATIVE TO PARTIAL MENISCECTOMY FOR TORN LATERAL DISCOID MENISCUS

Austin Ramme, MD, PhD¹, Eric Strauss, MD¹, Laith Jazrawi, MD¹ and Heather Taffet Gold, PhD², (1)NYU Hospital for Joint Diseases, New York, NY, (2)NYU School of Medicine, New York, NY

PS3-11

ESTIMATION OF DISABILITY WEIGHTS IN THE GENERAL POPULATION OF SOUTH KOREA USING A PAIRED COMPARISON

Min Woo Jo, PhD and Minsu Ock, MD, University of Ulsan College of Medicine, Seoul, South Korea

PS3-12

ANTICOAGULATION THERAPY FOR ATRIAL FIBRILLATION IN PATIENTS WITH DEMENTIA: A COST EFFECTIVENESS ANALYSIS

Estefania Ruiz Vargas, PhD¹, Luciano A. Sposato, MD, MBA, FAHA¹, Sepehr Nemati, PhD², Vladimir Hachinski, CM, MD, FRCPC, DSc¹ and Lauren E. Cipriano, Ph.D.², (1)Department of Clinical Neurological Sciences, London Health Sciences Centre, London, ON, Canada, (2)Ivey Business School, London, ON, Canada

PS3-13

COST-EFFECTIVENESS OF WARFARIN AND DABIGATRAN TO PREVENT STROKE IN ELDERLY MALE PATIENTS WITH ATRIAL FIBRILLATION

Viengneesee Thao, MS, University of Minnesota Twin-Cities, Minneapolis, MN and Karen M. Kuntz, ScD, University of Minnesota, Minneapolis, MN

PS3-14

AVERSION TO AMBIGUITY ABOUT THE RISK OF TREATMENT HARMS INFLUENCES DECISION MAKING AND VARIES BY LEVEL OF RISK AND AMBIGUITY

Nick Bansback, PhD, University of British Columbia; Centre for Clinical Epidemiology and Evaluation; Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, Mark Harrison, PhD, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada and Paul K. J. Han, MD, MA, MPH, Maine Medical Center Research Institute, Portland, ME

PS3-15

SHARING DIFFICULT CHOICES

Tatiana Barakshina, MBA, University of Illinois at Chicago, Aurora, IL and Alan Malter, PhD, Chicago, IL

PS3-16

“WHY NOT TAKE A RISK?” EXPLAINS SUBJECTS' EXPECTATIONS FOR ANTIBIOTICS AND PRIOR PRESCRIBING IN A LARGE ONLINE SAMPLE

David Broniatowski, PhD, The George Washington University, Washington, DC, Eili Klein, PhD, Johns Hopkins University, Baltimore, MD, Larissa May, MD, MSPH, The George Washington University Medical Faculty Associates, Washington, DC and Valerie Reyna, PhD, Cornell University, Ithaca, NY

PS3-17

THE USE OF PATIENT NARRATIVES IN A DECISION AID FOR LEFT VENTRICULAR ASSIST DEVICE PLACEMENT FOR HEART FAILURE: AN APPLICATION OF PRE-EXISTING GUIDELINES

Estevan Delgado, BA¹, Kristin Kostick, PhD, MA, MFA², Lidija Wilhelms, BA¹, Robert Volks, PhD³ and Jennifer Blumenthal-Barby, PhD, MA¹, (1)Center for Medical Ethics and Health Policy: Baylor College of Medicine, Houston, TX, (2)Center for Medical Ethics and Health Policy: Baylor College of Medicine, HOUSTON, TX, (3)MD Anderson Cancer Center, Houston, TX

PS3-18

USE OF FEEDBACK TO IMPROVE SYMBOLIC-NUMBER MAPPINGS

Rachel Eyler, PharmD, University of Connecticut School of Pharmacy, Storrs, CT, Sara Cordes, PhD, Boston College, Chestnut Hill, MA and Liana Fraenkel, MD, MPH, Yale School of Medicine, New Haven, CT

PS3-19

WHAT IS THE IMPACT OF DESCRIBING TREATMENTS AS 'NEW'?

Mark Harrison, PhD, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, Carlo Marra, Memorial University, St. John's, NF, Canada and Nick Bansback, PhD, University of British Columbia; Centre for Clinical Epidemiology and Evaluation; Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada

PS3-20

HEALTH INSURANCE DECISION-MAKING OF INDIVIDUALS WITH CHRONIC CONDITIONS

Ashley Housten, OTD, OTR/L, MSCI, MPA, Washington University School of Medicine, Saint Louis, MO, Kimberly Kaphingst, ScD, UNIVERSITY OF UTAH, DEPARTMENT OF COMMUNICATION, Salt Lake City, UT, Timothy McBride, PhD, Washington University in St Louis, Brown School of Social Work, St Louis, MO, Jingxia (Esther) Liu, PhD, Washington University School of Medicine Division of Biostatistics, Saint Louis, MO and Mary Politi, PhD, Washington University School of Medicine, St. Louis, MO

PS3-21

PHYSICIAN-PATIENT RELATIONSHIPS IN ORGAN TRANSPLANTATION FROM MARGINAL DONORS

Sara Kamran, MPH¹, Yvon Calmus, MD, PhD², Marie-Pascale Pomey, MD, PhD³ and Gwenaelle Vidal-Trecan, MD, PhD¹, (1)Department of public Heath, Paris center university hospitals, Assistance Publique - Hôpitaux de Paris, Paris, France, (2)Centre de transplantation hépatique, Pitié Salpêtrière hospital, Assistance Publique - Hôpitaux de Paris, Paris, France, (3)Department of Health Administration, Institut de Recherche en Santé Publique, Université de Montréal, Montreal, QC, Canada

PS3-22

PATIENT SURVEY RESULTS AFTER USE OF INTEGRATED EHR DECISION TOOL

Jon Keevil, MD¹, Margaret Leaf² and Amy Zelenski², (1)University of Wisconsin Hospital and Clinics, Madison, WI, (2)Madison, WI

PS3-23

IDENTIFYING PREDICTORS OF PREVENTIVE BEHAVIORS – AN EXPERIMENTAL STUDY

Maciej Kos, Northeastern University, Boston, MA, Anna Blajer-Golebiewska, University of Gdansk, Department of Economics, Sopot, Poland and Dagmara Wach, University of Gdańsk, Department of Economics, Sopot, Poland

PS3-24

AUTOMATIC HEURISTIC CUES OR SLOW AND DELIBERATE REASONING: USING COGNITIVE-EXPERIENTIAL SELF-THEORY TO EXPLAIN VARIABILITY IN UNDERSTANDING DECISION AID PROGNOSTIC ESTIMATES

Andrzej Kozikowski, PhD¹, Melissa Basile, PhD¹, Lauren Uhler, MPH² and Negin Hajizadeh, MD, MPH³, (1)North Shore LIJ Health System, Manhasset, NY, (2)Dell Medical School at the University of Texas at Austin, Austin, TX, (3)Hofstra North Shore-LIJ School of Medicine, Manhasset, NY

PS3-25

VALUES-CONSISTENT DECISIONS WITH USE OF A PRENATAL TESTING DECISION SUPPORT GUIDE

Miriam Kuppermann, PhD, MPH¹, Sanae Nakagawa, MA¹, Steven Gregorich, PhD², Rachel Freyre, RN¹ and Mary Norton, MD¹, (1)University of California, San Francisco, Department of Obstetrics, Gynecology & Reproductive Sciences, San Francisco, CA, (2)University of California, San Francisco, Department of Medicine, San Francisco, CA

PS3-26

ADHERING TO NEWLY PRESCRIBED MEDICATION IN THE ELDERLY: AN EXPERIMENTAL APPROACH

Miguel Oliveira, PhD, Center for Social Studies - University of Coimbra, Coimbra, Portugal, Vanessa Santos, MsC, Department of Psychology, School of Social Sciences, University of Évora, Évora, Portugal and António M. Diniz, PhD, Department of Psychology, Research Center in Education and Psychology, School of Social Sciences, University of Évora, Évora, Portugal

PS3-27

PATIENT PREFERENCES FOR COMMUNICATION OF TAILORED SURVIVAL ESTIMATES

Madhav Narayan, BA¹, Jacqueline Jones, PhD, RN², Laura Portalupi, MSW³, Colleen McIlvennan, DNP, ANP⁴, Daniel Matlock, MD, MPH⁵ and Larry Allen, MD, MHS⁴, (1)University of Colorado School of Medicine, Aurora, CO, (2)University of Colorado College of Nursing, Aurora, CO, (3)University of Colorado School of Medicine, Adult and Child Center for Health Outcomes Research and Delivery Science, Aurora, CO, (4)University of Colorado School of Medicine, Division of Cardiology, Aurora, CO, (5)University of Colorado School of Medicine, Division of General Internal Medicine, Aurora, CO

PS3-28

A QUALITY IMPROVEMENT STUDY TO INTEGRATE PATIENT DECISION AIDS INTO ORTHOPEDIC CARE

Karen R. Sepucha, PhD, Mahima Mangla, MPH, Thomas Cha, MD, MBA, Janet Dorrwachter, NP, Leigh Simmons, M.D., Emily Wendell, Lauren Leavitt, M.A. and Harry Rubash, MD, Massachusetts General Hospital, Boston, MA

PS3-29

DECISION-MAKING UNDER UNCERTAINTY: THE EFFECTS OF EXPLICIT PROBABILITY INFORMATION AND RISK PREFERENCES OF DOCTORS

Vlad V. Simianu, MD¹, Margaret A. Grounds, BA², Susan L. Joslyn, Ph.D.², Jared E. LeClerc, Ph.D.², Anne E. Pugel, MD³, Nidhi Agrawal, Ph.D.⁴, Rafael Alfonso-Cristancho, MD, MSc, PhD⁵, Abraham D. Flaxman, PhD⁶ and David R. Flum, MD, MPH¹, (1)Department of Surgery, University of Washington, Seattle, WA, (2)Department of Psychology, Seattle, WA, (3)Department of Surgery, Seattle, WA, (4)Foster School of Business, Seattle, WA, (5)Surgical Outcomes Research Center (SORCE), University of Washington, Seattle, WA, (6)Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA

PS3-30

PARTNER INFLUENCE ON ASTHMA PATIENTS' DECISION MAKING ABOUT PRESCRIPTION DRUGS

Katherine Treiman, PhD MPH¹, Megan Lewis, PhD², Kevin Betts, PhD³, Amie O'Donoghue, PhD³, Caroline Chandler, BA² and Paula Eguino Medina, BS², (1)RTI International, Rockville, MD, (2)RTI International, Research Triangle Park, NC, (3)Food and Drug Administration, Silver Spring, MD

PS3-31

DOES THE USE OF A DECISION AID IMPROVE DECISION MAKING IN PROSTHETIC HEART VALVE SELECTION? A MULTICENTER RANDOMIZED CLINICAL TRIAL

Nelleke M. Korteland¹, Yunus Ahmed², David R. Koolbergen, MD PhD², Marjan Brouwer³, Frederiek de Heer, MSc³, Jolanda Kluin, MD PhD³, Eline F. Bruggemans, MSc⁴, Robert J.M. Klautz, MD PhD⁴, Anne M. Stiggelbout, PhD⁴, Jeroen J.J. Bucx, MD PhD⁵, Ad J.J.C. Bogers, MD PhD¹ and Johanna Takkenberg, MD PhD¹, (1)Erasmus MC, Rotterdam, Netherlands, (2)AMC, Amsterdam, Netherlands, (3)UMCU, Utrecht, Netherlands, (4)LUMC, Leiden, Netherlands, (5)Diakonessenhuis Utrecht, Utrecht, Netherlands

PS3-32

“IT SOUNDS LIKE SOME BS”: ACCEPTANCE AND REJECTION OF GENETIC RISK COMMUNICATION

Erika A. Waters, PhD, MPH, Washington University School of Medicine, Saint Louis, MO, Linda Ball, PhD, Washington University, St. Louis, MO, Kimberly Carter, PhD, SIUE Department of Social Work, Edwardsville, IL and Sarah Gehlert, PhD, Washington University in St. Louis, Brown School, St. Louis, MO

PS3-33

LEGISLATION AND EVIDENCE FOR REIMBURSEMENT OF MEDICAL FOODS IN WORKER'S COMPENSATION SYSTEMS

Vicky Cao, Tracy Lin, PhD, Anna Oh, MSN, MPH, RN, Duyen-Anh Pham, PharmD, Candy Tsourounis, PharmD and Leslie Wilson, PhD, University of California, San Francisco, San Francisco, CA

PS3-34

GROWING COST OF COMPOUNDED DRUGS IN CALIFORNIA WORKERS' COMPENSATION (CAWC) SYSTEM

Leslie Wilson, PhD, Osama A Shoair, BPharm, PhD, Duyen-Anh Pham, PharmD, Tracy Lin, PhD and Vicky Cao, University of California, San Francisco, San Francisco, CA

PS3-35

OPTIMIZING REFERRAL TO RENAL CARE MANAGEMENT PROGRAM THROUGH USE OF A PREDICTIVE MODEL FOR TRANSITION TO DIALYSIS IN A MEDICARE ADVANTAGE POPULATION

Yanting Dong, PhD, Huyi Hines, PhD, Gil Haugh, Meghan Cockrell, MPH, Todd Prewitt, MD and Vipin Gopal, PhD, Humana, Louisville, KY

PS3-36

A MEASURE OF QUEBEC EMERGENCY PHYSICIANS' INTENTIONS TO USE WIKI-BASED REMINDERS TO PROMOTE BEST PRACTICES IN TRAUMA CARE

Audrey Dupuis, MA¹, Jean-Marc Chauny², Claudia Plourde³, Karine Sanogo⁴, Mélissa Tremblay⁵, Nicolas Elazhary⁶, Pierre-Luc Sylvain⁷, Sylvain Levac⁸, François Parent⁹, Marcel Rheault⁹, Annie Prévost¹⁰, Hugo Grenier¹⁰, Chantal Lanthier², Martin-Olivier Recher¹¹, France Légaré¹², Patrick Michel Archambault¹³ and Emilie Papillon-Dion¹⁴, (1)Université Laval, Québec, QC, Canada, (2)Hôpital du Sacré-Coeur de Montréal, Montréal, QC, Canada, (3)CSSS de la Côte-de-Gaspé (Hôpital de Gaspé), Gaspé, QC, Canada, (4)CISSS des Laurentides (Hôpital régional de Saint-Jérôme), Saint-Jérôme, QC, Canada, (5)CIUSSS du Saguenay-Lac-Saint-Jean (Hôpital de Chicoutimi), Chicoutimi, QC, Canada, (6)Centre de recherche du CHUS, Sherbrooke, QC, Canada, (7)CISSS du Bas-Saint-Laurent (Centre Hospitalier De Matane), Matane, QC, Canada, (8)CSSS de la Baie-des-Chaleurs (Hôpital de Maria), Maria, QC, Canada, (9)CIUSSS Mauricie-et-Centre-du-Québec (Centre hospitalier régional de Trois-Rivières), Trois-Rivières, QC, Canada, (10)CISSS CA (Hôpital de Thetford Mines), Thetford Mines, QC, Canada, (11)CISSS des Laurentides (Hôpital de Saint-Eustache), Saint-Eustache, QC, Canada, (12)Chaire de recherche du Canada en implantation de la prise de décision partagée dans les soins primaires, Université Laval, Québec, QC, Canada, (13)CISSS CA, Secteur Alphonse-Desjardins (CHAU Hôtel-Dieu de Lévis), Lévis, QC, Canada, (14)CISSS de Chaudiere-Appalaches, Levis, QC, Canada

PS3-37

VARIABLE SELECTION FOR PROPENSITY SCORE MODELS IN COMPARATIVE EFFECTIVENESS RESEARCH ON CHRONIC CORONARY ARTERY DISEASE

Alexandra G. Ellis, MSc¹, Thomas A. Trikalinos, MD¹, Benjamin S. Wessler, MD², John B. Wong, MD² and Issa J. Dahabreh, MD, MS¹, (1)Brown University, Providence, RI, (2)Tufts Medical Center, Boston, MA

PS3-38

FIRST-DOLLAR MEDICARE SUPPLEMENT PLANS ARE ASSOCIATED WITH HIGHER QUALITY OF CARE

Timothy Wells, PhD¹, Kevin Hawkins, PhD¹, Gandhi Bhattarai, PhD¹, Yan Cheng, MS¹, Douglas Armstrong, MHS² and Charlotte Yeh, MD², (1)OptumInsight, Ann Arbor, MI, (2)AARP Services, Inc., Washington, DC

PS3-39

MODELING EMERGENCY DEPARTMENT UTILIZATION

Tina Hernandez-Boussard, PhD, MPH, Stanford University, Palo Alto, CA, Doug Morrison, MS, Stanford, CA and Sanjay Basu, MD, PhD, Stanford University, Stanford, CA

PS3-40

IMPACT OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS ON THE RISK OF CARDIOVACULAR-RELATED HOSPITALIZATIONS

Niranjan Kathe, M.S., Anuj Shah, B. Pharm and Qayyim Said, Ph.D., University of Arkansas for Medical Sciences, Little Rock, AR

PS3-41

DECISION QUALITY AND EDUCATIONAL NEEDS OF HEALTHCARE PERSONNEL TO IMPROVE DECISION-MAKING ABOUT MANAGING HOME HEALTHCARE HAZARDS

Celia E. Wills, PhD, RN¹, Barbara Polivka, PhD, RN², Amy Darragh, PhD³, Steven Lavender, PhD³, Carolyn Sommerich, PhD³ and Stredney Donald, MA⁴, (1)The Ohio State University, Columbus, OH, (2)University of Louisville, Louisville, KY, (3)Ohio State University, Columbus, OH, (4)Ohio Supercomputer Center, Columbus, OH

PS3-42

COST-EFFECTIVENESS ANALYSIS OF HIV PREVENTION FOR NEGLECTED, AT-RISK WOMEN IN VIETNAM: IMPLICATIONS FOR PRIORITIZING BEHAVIORAL INTERVENTION RESOURCES

Van T. Nghiem, M.S.P.H.¹, Theodore M. Hammett, Ph.D.², Lincy S. Lal, Pharm.D., Ph.D.³ and J. Michael Swint, Ph.D.³, (1)The University of Texas MD Anderson Cancer Center, Department of Health Services Research, Houston, TX, (2)Abt Associates, Cambridge, MA, (3)The University of Texas School of Public Health, Department of Management, Policy and Community Health, Houston, TX

PS3-43

IMPACT OF TELEHOMECARE PROGRAM ON MONITORING PARAMETERS AMONG COPD AND HF PATIENTS

Valeria E. Rac, MD, PhD¹, Yeva Sahakyan, MD, MPH¹, Nida Shahid, HBSc., CCRP¹, Aleksandra Stanimirovic, MSc, PhD (candidate)¹, Iris Fan, BA², Welson Ryan¹, Petros Pechlivanoglou, MSc, PhD¹, Lusine Abrahamyan, MD MPH PhD¹ and Murray Krahn, MD, Msc, FRCPC², (1)Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto, Toronto, ON, Canada, (2)Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada

PS3-44

A HEALTHCARE SETTING TRANSITION MODEL FOR WISCONSIN MEDICAID LONG TERM CARE POPULATION

Elise Wu, PhD, Merck, north wales, PA

PS3-45

USING PLAN DO CHECK ACT (PDCA) QUALITY IMPROVEMENT CYCLES TO IMPLEMENT PREVENTION RECOMMENDATIONS AMONG PRIMARY CARE PHYSICIANS IN SWITZERLAND

Regula Cardinaux, PhD, Sophie Guinand, MD, Jacques Cornuz, MD, MPH and Reto Auer, MD, MAS, University of Lausanne, Lausanne, Switzerland

PS3-46

SOCIAL NETWORK CHARACTERISTICS AND PREFERENCES FOR INFORMATION AS A SUBSTITUTE DECISION MAKER IN AN INTENSIVE CARE UNIT SIMULATION

Jorie Butler, PhD¹, Eliotte Hirshberg, MD², Ramona Hopkins, PhD³, Emily Wilson, MS⁴, James Orme, MD⁵, Sarah Beesley, MD⁶, Kathryn Kuttler, PhD⁷ and Samuel Brown, MD, MS⁶, (1)University of Utah, Salt Lake City, UT, (2)University of Utah, Division of Pulmonary Medicine, Department of Internal Medicine, Salt Lake City, UT, (3)Psychology Department and Neuroscience Center, Provo, UT, (4)Center for Humanizing Critical Care, Intermountain Healthcare, Murray, UT, (5)Division of Pulmonary Medicine, Department of Internal Medicine, Salt Lake City, UT, (6)Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT, (7)Homer Warner Center for Informatics Research, Murray, UT

PS3-47

DECISION MAKING IN EXPANDED NEWBORN SCREENING; A QUALITATIVE STUDY EXAMINING CONSENT AND COMMUNICATION PREFERENCES OF PARENTS IN THE UK

Nimarta Dharni, BSc, MSc, PhD¹, Rebecca Bennett, PhD², Stuart Wright, BSc, MSc³ and Fiona Ulph, BSc, MSc, PhD¹, (1)Manchester Centre for Health Psychology, The University of Manchester, Manchester, United Kingdom, (2)School of Law, University of Manchester, Manchester, United Kingdom, (3)Manchester Centre for Health Economics, The University of Manchester, Manchester, United Kingdom

PS3-48

PARENTS PREFER ACTIVE AND COLLABORATIVE PARTICIPATION IN DECISION REGARDING THEIR CHILD WITH MEDICAL COMPLEXITY

David Fox, MD, University of Colorado, Denver, Aurora, CO, Elizabeth Campagna, MS, Children's Outcomes Research Program, Aurora, CO and Allison Kempe, MD, MPH, Children's Outcome Research Program, Aurora, CO

PS3-49

SELECTION OF KEY PROMIS DOMAINS FOR A PREFERENCE-BASED SCORING SYSTEM

Janel Hanmer, MD, PhD¹, David Feeny, PhD², Baruch Fischhoff, PhD³, Ron Hays, PhD⁴, Rachel Hess, MD, MS⁵, Paul Pilkonis, PhD³, Dennis Revicki, PhD⁶, Mark S. Roberts, MD, MPH⁷, Joel Tsevat, MD⁸ and Lan Yu, PhD⁹, (1)The University of Pittsburgh, Pittsburgh, PA, (2)Hamilton, ON, Canada, (3)Pittsburgh, PA, (4)Los Angeles, CA, (5)University of Utah, Salt Lake City, UT, (6)Bethesda, MD, (7)Department of Industrial Engineering, University of Pittsburgh, Pittsburgh, PA, (8)Cincinnati, OH, (9)University of Pittsburgh, Pittsburgh, PA

PS3-50

SHARED DECISION MAKING AND REGRET PLAYS CRITICAL ROLES OF POSTTRAUMATIC GROWTH: A LONGITUDINAL STUDY

Ching-Wen Lai¹, Yu-Hsuan Tsao¹ and Chi-Chang Chang, PhD², (1)chungshan medical university, TAICHUNG, Taiwan, (2)ChungShan Medical University, Taichung, Taiwan

PS3-51

THE VALUE OF DATA TRANSPARENCY AT THE POINT OF CARE

Peter Lodato, MPH¹, Jennifer C. Goldsack, MS, MBA², Susan Mascioli, MS, BSN, RN, CPHQ, NEA-BC² and Seema S. Sonnad, PhD¹, (1)Christiana Care Health System Value Institute, Newark, DE, (2)Christiana Care Health System, Newark, DE

PS3-52

DO INDIVIDUALS' UTILITIES FOR DIVERSE HEALTH STATES TEND TO HAVE A CONSISTENT RANK WITHIN A POPULATION?

Irene Fischer, MPH¹, Rob Culverhouse, PhD¹, Michael Hagen, MD² and Walton Sumner, MD¹, (1)Washington University School of Medicine, St. Louis, MO, (2)University of Kentucky, Lexington, KY

PS3-53

Man Wah Yeung¹, Mark Loeb², George Tomlinson³ and Beate Sander³, (1)Public Health Ontario, Toronto, ON, Canada, (2)McMaster University, Hamilton, ON, Canada, (3)University of Toronto, Toronto, ON, Canada

PS3-54

USING TECHNOLOGY AND PROVIDER ASSESSMENT TO REDESIGN CLINICAL RECOGNITION SYSTEMS

Muge Capan, PhD, Pan Wu, PhD, Michele Campbell, RN, MSM, CPHQ, Susan Mascioli, MS, BSN, RN, CPHQ, NEA-BC and Eric V. Jackson, Jr., MD, MBA, Christiana Care Health System, Newark, DE

PS3-55

LOOPY NO MORE: PROBABILISTIC SENSITIVITY ANALYSIS IN MICROSIMULATION MODELS

Jagpreet Chhatwal, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, Kan Li, MS, Houston, TX, Andrew Briggs, DPhil, University of Glasgow, Glasgow, United Kingdom, Elisabeth A.L. Fenwick, PhD, ICON plc, Oxford, United Kingdom and Mark S. Roberts, MD, MPH, Department of Health Policy and Management, University of Pittsburgh, Pittsburgh, PA

PS3-56

COMPARISON OF TIMED AUTOMATA WITH DISCRETE EVENT SIMULATION FOR MODELING PERSONALIZED TREATMENT DECISIONS: THE CASE OF METASTATIC CASTRATION RESISTANT PROSTATE CANCER

Koen Degeling, BSc, Hendrik Koffijberg, PhD, Stefano Schivo, PhD, Rom Langerak, PhD and Maarten J. IJzerman, PhD, University of Twente, Enschede, Netherlands

PS3-57

CHOICE OF TIME SCALE FOR MODELING LONG-TERM SURVIVAL IN A COST-EFFECTIVENESS ANALYSIS: AN ILLUSTRATION

Bart Ferket, MD, PhD¹, Ankur Pandya, PhD², Zach Feldman, MSc³, M.G. Myriam Hunink, MD, PhD⁴ and Madhu Mazumdar, PhD¹, (1)Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, (2)Harvard T.H. Chan School of Public Health, Boston, MA, (3)Icahn School of Medicine at Mount Sinai, New York, NY, (4)Center for Health Decision Science, Harvard T.H.Chan School of Public Health, Boston, MA

PS3-58

RETURN-TO-WORK DECISIONS IN REHABILITATION: HOW TO GET WORKERS, CLINICIANS AND STAKEHOLDERS ON THE SAME PAGE?

Marie-France Coutu, PhD¹, Marie-Elise Labrecque, MA¹, France Legare, MD, PhD, CCFP², Marie-Jose Durand, PhD¹ and Dawn Stacey, RN, PhD, CON (C)³, (1)Université de Sherbrooke, Longueuil, QC, Canada, (2)Université Laval, Quebec City, QC, Canada, (3)University of Ottawa, Ottawa, ON, Canada

PS3-59

VALIDATION OF THE CONCEPTUAL FRAMEWORK OF THE DIVA QUESTIONNAIRE

Luc Martinez, MD¹, Fatoumata Fofana, MSc², Benoit Arnould, PhD², Didier Duhot, MD¹, François Denis, MD³, Pascale Arnould, MD¹, Jean-Luc Gallais, MD¹, Guillaume Coindard, MD¹, Didier Seyler, MD¹, François Raineri, MD¹, Khadra Benmedjahed² and Béatrice Tugaut², (1)French Society of General Medicine (SFMG), Issy les Moulineaux, France, (2)Mapi, Health Economics and Outcomes Research and Strategic Market Access, Lyon, France, (3)University Hospital, Bacteriology and Virologie department, Limoges, France

PS3-60

THE PRIMACY OF PRIORS: THE EFFECT OF BAYESIAN PRIOR SELECTION ON THE ESTIMATED RISK OF INDUCED VZV DISSEMINATION FROM THE SHINGLES VACCINE IN IMMUNOCOMPROMISED PATIENTS

Marc Vacquier, MSc¹, Jordan Hinahara, BA¹, Szu-Yu Zoe Kao, MA¹ and Karen M. Kuntz, ScD², (1)University of Minnesota School of Public Health, Minneapolis, MN, (2)University of Minnesota, Minneapolis, MN

37th Annual Meeting of the Society for Medical Decision Making

October 18 - 21, 2015

Menu

POSTER SESSION III & CONTINENTAL BREAKFAST